Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation

Volume: 364, Issue: 1, Pages: 22 - 32
Published: Jan 6, 2011
Abstract
Evidence suggests that gut flora may play an important role in the pathophysiology of the irritable bowel syndrome (IBS). We evaluated rifaximin, a minimally absorbed antibiotic, as treatment for...
Paper Details
Title
Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation
Published Date
Jan 6, 2011
Volume
364
Issue
1
Pages
22 - 32
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.